Capital A Wealth Management’s Trueblue TBI Stock Holding History

Capital A Wealth Management’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9	Closed	-$76	–	892
2024 Q4	$76	Buy	+9	New	+$69	﹤0.01%	788

Other funds holding TBI

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ACM

Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Capital A Wealth Management's TBI Position: Q1 2025 in Review

Capital A Wealth Management sold out of Trueblue (TBI) in Q1 2025, closing a stake of 9 shares — an estimated $76 sold.

Capital A Wealth Management first reported a position in TBI in Q4 2024 and held it in 1 quarter. The position peaked at $76 in Q4 2024. 111 funds tracked by Wall St. Rank hold TBI as of Q1 2025.

Capital A Wealth Management reported no remaining Trueblue position as of Q1 2025 after selling out during the quarter.
Capital A Wealth Management sold 9 Trueblue shares in Q1 2025, an estimated $76.
Capital A Wealth Management first reported a position in Trueblue in Q4 2024 and held it in 1 quarter.
Capital A Wealth Management's Trueblue position peaked at $76 in Q4 2024.
111 funds tracked by Wall St. Rank held Trueblue as of Q1 2025.

Based on Capital A Wealth Management's 13F filing for Q1 2025, filed 2 May 2025.